Education
About Us
Working with TipRanks
Follow Us
CureVac (CVAC)
NASDAQ:CVAC
Total Valuation
CureVac has a market cap or net worth of $668.43M. The enterprise value is $92.14M.
Market Cap$668.43M
Enterprise Value$92.14M
Share Statistics
CureVac has 224.31M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding224.31M
Owened by Insiders
Owened by Instutions0.35%
Financial Efficiency
CureVac’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee$543,242.205
Profits Per Employee$110,628.019
Employee Count999
Asset Turnover0.07
Inventory Turnover5.01
Valuation Ratios
The current PE Ratio of CureVac is -3.23. CureVac’s PEG ratio is 0.30.
PE Ratio-3.23
PS Ratio15.62
PB Ratio1.62
Price to Fair Value1.62
Price to FCF-2.60
Price to Operating Cash Flow-3.13
PEG Ratio0.30
Income Statement
In the last 12 months, CureVac had revenue of $542.70M and earned $110.52M in profits. Earnings per share was -$1.01.
Revenue$542.70M
Gross Profit$378.59M
Operating Income$131.04M
Pretax Income$145.17M
Net Income$110.52M
EBITDA155.72M
Earnings Per Share (EPS)-1.01
Cash Flow
In the last 12 months, operating cash flow was $128.45M and capital expenditures -$29.45M, giving a free cash flow of $99.35M billion.
Operating Cash Flow$128.45M
Free Cash Flow$99.35M
Free Cash Flow per Share$0.44
Dividends & Yields
CureVac pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.90
52-Week Price Change-3.38%
50-Day Moving Average3.19
200-Day Moving Average3.20
Relative Strength Index (RSI)36.78
Average Volume (3m)648.05K
Important Dates
CureVac upcoming earnings date is May 21, 2025, TBA.
Last Earnings DateApr 10, 2025
Next Earnings DateMay 21, 2025
Ex-Dividend Date―
Financial Position
CureVac as a current ratio of 2.57, with Debt / Equity ratio of 0.08
Current Ratio2.57
Quick Ratio2.43
Debt to Market Cap0.00
Net Debt to EBITDA―
Interest Coverage Ratio-109.99
Taxes
In the past 12 months, CureVac has paid $34.66M in taxes.
Income Tax$34.66M
Effective Tax Rate-0.08%
Enterprise Valuation
CureVac EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
CureVac has $554.92M in cash and marketable securities with $40.13M in debt, giving a net cash position of -$514.79M billion.
Cash & Marketable Securities$554.92M
Total Debt$40.13M
Net Cash-$514.79M
Net Cash Per Share-$2.30
Tangible Book Value Per Share$2.22
Margins
Gross margin is -131.34%, with operating margin of -510.08%, and net profit margin of -483.96%.
Gross Margin-131.34%
Operating Margin-510.08%
Pretax Margin-483.59%
Net Profit Margin-483.96%
EBITDA Margin-435.45%
EBIT Margin-478.95%
Analyst Forecast
The average price target for CureVac is $9.25, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$9.25
Price Target Upside210.40%
Analyst ConsensusHold
Analyst Count3
Revenue Growth Forecast1202.27%
EPS Growth Forecast